New Mountain Capital-backed health tech Datavant is working with JPMorgan on a strategic review, Axios Pro has learned.
State of play: NMC's exit strategy for its health tech assets is coming into focus after a planned portfolio sale to former private equity chief Matt Holt collapsed.
